- February 25, 2020
- Heidi Hagen
- Subbu Viswanathan
- Posted in Commercial Scale
Quality Management Systems for advanced therapies, Part 1: the essentials
Note: this post is the first in a five-part series on Quality Management Systems (including cGMP and Quality Risk Management)...
- February 25, 2020
- Heidi Hagen
- Subbu Viswanathan
- Posted in Commercial Scale
Quality Management Systems for advanced therapies, Part 2: six areas of focus
Note: this post is the second in a five-part series on Quality Management Systems (including cGMP and Quality Risk Management)...
- February 21, 2020
- Heidi Hagen
- Cristophe Suchet
- Posted in Commercial Scale
Data management for advanced therapies, Part 8: the benefits of a strategic approach
Note: this post is the eighth in an eight-part series on data management strategies for personalized therapeutics, such as cell...
- February 19, 2020
- Heidi Hagen
- Cristophe Suchet
- Posted in Commercial Scale
Data management for advanced therapies, Part 7: summing up the strategies
Note: this post is the seventh in an eight-part series on data management strategies for personalized therapeutics, such as cell...
- February 12, 2020
- Heidi Hagen
- Cristophe Suchet
- Posted in Commercial Scale
Data management for advanced therapies, Part 6: efficiencies across the supply chain
Note: this post is the sixth in an eight-part series on data management strategies for personalized therapies, such as cell...
- February 11, 2020
- Heidi Hagen
- Cristophe Suchet
- Posted in Commercial Scale
Data management for advanced therapies, Part 5: traceability
Note: this post is the fifth in an eight-part series on data management strategies for personalized therapies, such as cell...
- February 5, 2020
- Heidi Hagen
- Posted in Commercial Scale
Our Series C and the road ahead
Today, we announced Vineti’s $35 million Series C round of investment. A first-of-its-kind investor coalition of industry leaders — Cardinal Health,...